894
S. Takizawa et al. / Tetrahedron: Asymmetry 21 (2010) 891–894
Table 3
Substrate scope using organocatalysts 1a and 2
R1
R1
NHTs
NTs
R2
10 mol % of catalyst 1a (or 2)
*
+
R2
CCl4 (or CHCl3), rt
NO2
10
NO2
11
12
Entry
R1
R2
Cat
Time (h)
Yielda (%)
eeb,c (%)
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
2-Furyl 10a
10a
10a
10a
10a
10a
10a
10a
10a
10a
10a
10a
Ph 11b
11b
4-F–C6H4 11c
11c
4-Cl–C6H4 11d
11d
4-MeO–C6H4 11e
11e
4-NC–C6H4 11f
11f
2-Naphthyl 11g
11g
4-Br–C6H4 11a
11a
11a
1a
2
1a
2
1a
2
1a
2
1a
2
1a
2
1a
1a
1a
72
120
96
120
72
72
96
168
72
72
72
120
72
72
72
77
54
77
60
94
76
35
14
98
85
89
47
23
16
NR
12b
12b
12c
12c
12d
12d
12e
12e
12f
57 (ꢀ)
57 (+)
51 (ꢀ)
47 (+)
47 (ꢀ)
51 (+)
43 (ꢀ)
40 (+)
51 (ꢀ)
47 (+)
47 (ꢀ)
47 (+)
29 (ꢀ)
21 (ꢀ)
—
12f
12g
12g
12h
12i
4-MeO–C6H4 10b
2,4-diMeO–C6H3 10c
Ph 10d
a
b
c
Isolated yield.
Determined by HPLC (Daicel Chiralcel OD-H).
The sign of specific rotation is indicated in parentheses.
6. (a) Luo, S.; Zhang, B.; He, J.; Janczuk, A.; Wang, P. G.; Chenga, J.-P. Tetrahedron
Lett. 2002, 43, 7369; (b) Deb, I.; Dadwal, M.; Mobin, S. M.; Namboothiri, I. N. N.
Org. Lett. 2006, 8, 1201; (c) Mohan, R.; Rastogi, N.; Namboothiri, I. N. N.; Mobin,
S. M.; Panda, D. Bioorg. Med. Chem. 2006, 14, 8073; (d) Rastogi, N.; Mohan, R.;
Panda, D.; Mobin, S. M.; Namboothiri, I. N. Org. Biomol. Chem. 2006, 4, 3211; (e)
Deb, I.; Shanbhag, P.; Mobin, S. M.; Namboothiri, I. N. N. Eur. J. Org. Chem. 2009,
14, 4091.
Acknowledgments
This work was supported by a Grant-in-Aid for Scientific Re-
search from the Ministry of Education, Culture, Sports, Science
and Technology, Japan, and Takeda Science Foundation. We thank
the technical staff of the Comprehensive Analysis Center of ISIR,
Osaka University.
7. (S)-1a: 1H NMR (270 MHz, CDCl3): d 6.48–7.75 (17H, m); 13C NMR (37.7 MHz,
CDCl3): d 153.0, 149.3, 135.7, 135.2, 134.4, 134.0, 133.5, 131.3, 130.9, 130.2,
128.9, 128.7, 128.5, 128.0, 127.9, 127.7, 126.9, 126.5, 124.8, 124.7, 123.7, 123.1,
118.3, 113.1; HRMS (ESI) m/z calcd for C29H21N2O2, 429.1525 [(M+H)+]: found,
429.1515; ½a 2D0
¼ ꢀ56:3 (c 0.5, CHCl3).
ꢁ
References
8. (S)-2: 1H NMR (270 MHz, CDCl3): d 6.66–7.64 (9H, m), 2.74 (4H, br s), 2.18 (4H,
br s), 1.20–1.70 (8H, m); 13C NMR (37.7 MHz, CDCl3): d 148.3, 147.7, 136.4,
136.3, 135.8, 134.9, 134.1, 131.0, 130.8, 130.6, 129.5, 129.3, 129.3, 127.9, 127.3,
127.1, 127.0, 126.2, 125.1, 122.7, 121.6, 119.0, 28.9, 26.9, 23.0, 22.9, 22.6;
HRMS (ESI) m/z calcd for C29H29N2O2, 437.2151 [(M+H)+]: found, 437.2169;
1. (a) Morita, K.-I.; Suzuki, Z.; Hirose, H. Bull. Chem. Soc. Jpn. 1968, 41, 2815; (b)
Baylis A. B.; Hillman M. E. D. German Patent 2,155,113, 1972. [Chem. Abstr.
1972, 77, 34174q].
2. (a) Basavaiah, D.; Rao, A. J.; Satyanarayana, T. Chem. Rev. 2003, 103, 811; (b)
Masson, G.; Housseman, C.; Zhu, J. Angew. Chem., Int. Ed. 2007, 46, 4614; (c) Ma,
G.-N.; Jiang, J.-J.; Shi, M.; Wei, Y. Chem. Commun. 2009, 5496; (d) Declerck, V.;
Martinez, J.; Lamaty, F. Chem. Rev. 2009, 109, 1; (e) Mansilla, J.; Saa, J. M.
Molecules 2010, 15, 709; (f) Wei, Y.; Shi, M. Acc. Chem. Res., in press,
3. (a) Shi, M.;Xu, Y.-M. Angew. Chem., Int. Ed. 2002, 41, 4507; (b)Balan, D.; Adolfsson,
H. Tetrahedron Lett. 2003, 44, 2521; (c) Kawahara, S.; Nakano, A.; Esumi, T.;
Iwabuchi, Y.; Hatakeyama, S. Org. Lett. 2003, 5, 3103; (d) Shi, M.; Chen, L.-H. Chem.
Commun. 2003, 1310; (e) Matsui, K.; Takizawa, S.; Sasai, H. J. Am. Chem. Soc. 2005,
127, 3680; (f) Shi, M.; Chen, L.-H.; Li, C.-Q. J. Am. Chem. Soc. 2005, 127, 3790; (g)
Shi, M.;Li, C.-Q. Tetrahedron: Asymmetry 2005, 16, 1385; (h)Shi, M.;Xu, Y.-M.;Shi,
Y.-L. Chem. Eur. J. 2005, 11, 1794; (i) Raheem, I. T.; Jacobsen, E. N. Adv. Synth. Catal.
2005, 347, 1701; (j) Shi, M.; Chen, L.-H.; Teng, W.-D. Adv. Synth. Catal. 2005, 347,
1781; (k) Matsui, K.; Tanaka, K.; Horii, A.; Takizawa, S.; Sasai, H. Tetrahedron:
Asymmetry 2006, 17, 578; (l) Liu, Y.-H.; Chen, L.-H.; Shi, M. Adv. Synth. Catal. 2006,
348, 973; (m) Matsui, K.; Takizawa, S.; Sasai, H. Synlett 2006, 761; (n) Gausepohl,
R.; Buskens, P.; Kleinen, J.; Bruckmann, A.; Lehmann, C. W.; Klankermayer, J.;
Leitner, W. Angew. Chem., Int. Ed. 2006, 45, 3689; (o) Vesely, J.; Dziedzic, P.;
Cordova, A. Tetrahedron Lett. 2007, 48, 6900; (p) Ito, K.; Nishida, K.; Gotanda, T.
Tetrahedron Lett. 2007, 48, 6147; (q) Utsumi, N.; Zhang, H.; Tanaka, F.; Barbas, C.
F., III Angew. Chem., Int. Ed. 2007, 46, 1878; (r) Abermil, N.; Masson, G.; Zhu, J. J. Am.
Chem. Soc. 2008, 130, 12596; (s) He, L.; Zhang, Y.-R.; Huang, X.-L.; Ye, S. Synthesis
2008, 2825; (t) Guan, X.-Y.; Jiang, Y.-Q.; Shi, M. Eur. J. Org. Chem. 2008, 2150; (u)
Abermil, N.;Masson, G.; Zhu, J. Org. Lett. 2009, 11, 4648; (v)Garnier, J.-M.; Anstiss,
C.; Liu, F. Adv. Synth. Catal. 2009, 351, 331; (w) Garnier, J.-M.; Liu, F. Org. Biomol.
Chem. 2009, 7, 1272; (x) Abermil, N.; Masson, G.; Zhu, J. Adv. Synth. Catal. 2010,
352, 656.
½ ꢁ ¼ ꢀ109 (c 0.5, CHCl3).
a 2D0
9. Known compounds 3, 5 and 7 were synthesized following their reported
procedures. Compound 3, Young, M. B.; Barrow, J. C.; Glass, K. L.; Lundell, G. F.;
Newton, C. L.; Pellicore, J. M. Rittle, K. E.; Selnick, H. G. Stauffer, K. J.; Vacca, J. P.;
Williams, P. D.; Bohn, D.; Clayton, F. C.; Cook, J. J.; Krueger, J. A.; Kuo, L. C. S.;
Lewis, D.; Lucas, B. J.; McMasters, D. R.; Miller-Stein, C.; Pietrak, B. L.; Wallace,
A. A.; White, R. B.; Wong, B.; Yan, Y.; Nantermet, P. G. J. Med. Chem. 2004, 47,
2995. Compound 5, Ma, L.; Jin, R.-Z.; Lü, G.-H.; Bian, Z.; Ding, M. X.; Gao, L.-X.
Synthesis 2007, 2461. Compound 7, Takasaki, M.; Motoyama, Y.; Yoon, S.-H.;
Mochida, I.; Nagashima, H. J. Org. Chem. 2007, 72, 10291.
10. (S)-1b: 1H NMR (270 MHz, CDCl3): d 7.08–7.77 (17H, m); 13C NMR (37.7 MHz,
CDCl3): d 153.1, 146.9, 138.0, 134.8, 133.7, 133.0, 131.6, 130.7, 130.5, 130.2,
129.1, 129.1, 128.6, 128.5, 128.1, 126.9, 126.8, 125.8, 124.4, 124.2, 123.9, 123.5,
128.5, 118.3, 114.1, 112.2; HRMS (ESI) m/z calcd for C29H21N2O2, 429.1525
[(M+H)+]: found, 429.1511; ½a 2D0
¼ ꢀ94:8 (c 0.5, CHCl3).
ꢁ
11. (S)-1c: 1H NMR (270 MHz, CDCl3): d 6.96–7.94 (17H, m); 13C NMR (37.7 MHz,
CDCl3): d 154.6, 151.3, 138.5, 136.8, 135.7, 134.7, 132.7, 132.2, 131.0, 130.7,
130.4, 130.3, 129.0, 128.9, 127.3, 126.9, 125.5, 125.5, 125.3, 124.2, 123.9, 119.2,
116.9, 114.8; HRMS (ESI) m/z calcd for C29H21N2O2, 429.1525 [(M+H)+]: found,
429.1511; ½a 2D0
¼ ꢀ104 (c 0.5, CHCl3).
ꢁ
12. Cram, D. J.; Helgeson, R. C.; Peacock, S. C.; Kaplan, L. J.; Domeier, L. A.; Moreau,
P.; Koga, K.; Mayer, J. M.; Chao, Y.; Siegel, M. G.; Hoffman, D. H.; Sogah, G. D. Y.
J. Org. Chem. 1978, 43, 1930.
13. General experimental procedure (Table 3): To
a solution of organocatalyst
(10 mol %) in solvent (0.2 mL) was added nitroalkene 10 (0.2 mmol) and imine
11 (0.1 mmol) at rt. The reaction mixture was stirred until the reaction had
reached completion by monitoring with TLC analysis. The mixture was directly
purified by flash column chromatography (SiO2, n-hexane/EtOAc = 7/2) to give
the corresponding adduct 12 as a yellow solid. All products were characterized
by 1H, 13C NMR, MS, and IR spectroscopy, and were identical in all respects
with reported by Namboothiri et al.6d Determination of absolute configurations
of 12 is now in progress.
4. Wang, X.; Chen, Y.-F.; Niu, L.-F.; Xu, P.-F. Org. Lett. 2009, 11, 3310.
5. (a) Takizawa, S.; Katayama, T.; Somei, H.; Asano, Y.; Yoshida, T.; Kameyama, C.;
Rajesh, D.; Onitsuka, K.; Suzuki, T.; Mikami, M.; Yamataka, H.; Jayaprakash, D.;
Sasai, H. Tetrahedron 2008, 64, 3361; (b) Takizawa, S.; Matsui, K.; Sasai, H. J.
Synth. Org. Chem. Jpn. 2007, 65, 1089.